Enorama Pharma AB (publ) (STO: ERMA)

Market Cap	247.34M
Revenue (ttm)	13.26M
Net Income (ttm)	-35.55M
Shares Out	60.47M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,707
Open	4.250
Previous Close	4.230
Day's Range	3.880 - 4.250
52-Week Range	2.000 - 10.500
Beta	1.43
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 15, 2024

About Enorama Pharma AB

Enorama Pharma AB (publ), a pharmaceutical company, produces and supplies medical chewing gum and other nicotine products. It also offers nicotine pouches and medical cannabis products. Enorama Pharma AB (publ) was incorporated in 2006 and is based in Malmö, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 5
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ERMA

Financial Performance

In 2023, Enorama Pharma AB's revenue was 1.36 million, a decrease of -80.17% compared to the previous year's 6.85 million. Losses were -44.61 million, 6.15% more than in 2022.